Stock Report

Shukra Pharmaceuticals Q3FY22 net profit at Rs. 4.80 lakhs



Posted On : 2022-02-13 18:36:41( TIMEZONE : IST )

Shukra Pharmaceuticals Q3FY22 net profit at Rs. 4.80 lakhs

has reported Standalone financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 3.0207 crores during the period ended December 31, 2021 as compared to Rs. 5.3855 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 0.0480 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.0192 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 0.31 for the period ended December 31, 2021 as compared to Rs. 0.12 for the period ended September 30, 2021.

Financials Q3 FY2022 Q2 FY2022 % Change
Total Income ₹ 3.0207 crs ₹5.3855 crs Up Tick / Down Tick-43.91%
Net Profit ₹0.0480 crs ₹0.0192 crs Up Tick / Down Tick150.00%
EPS ₹0.31 ₹0.12 Up Tick / Down Tick158.33%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 3.0207 crores during the period ended December 31, 2021 as compared to Rs.4.4194 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.0.0480 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.2070 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.0.31 for the period ended December 31, 2021 as compared to Rs.1.32 for the period ended December 31, 2020.

Financials Q3 FY2022 Q3 FY2021 % Change
Total Income ₹ 3.0207 crs ₹4.4194 crs Up Tick / Down Tick-31.65%
Net Profit ₹0.0480 crs ₹0.2070 crs Up Tick / Down Tick-76.81%
EPS ₹0.31 ₹1.32 Up Tick / Down Tick-76.52%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.11.5941 crores during the 9 Months period ended December 31, 2021 as compared to Rs.7.4429 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.0.1043 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.2847 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.0.67 for the 9 Months period ended December 31, 2021 as compared to Rs.1.82 for the 9 Months period ended December 31, 2020.

Financials 9 Months Ended FY2022 9 Months Ended FY2021 % Change
Total Income ₹11.5941 crs ₹7.4429 crs Up Tick / Down Tick55.77%
Net Profit ₹0.1043 crs ₹0.2847 crs Up Tick / Down Tick-63.36%
EPS ₹0.67 ₹1.82 Up Tick / Down Tick-63.19%

Source : Equity Bulls

Keywords

ShukraPharmaceuticals Q3FY22 9MFY22 ResultUpdate